News

An illustration of black cats sitting on white RNA strands against a dark blue background

Mapped to purrfection

MIT News

November 4, 2025

Burge Lab researchers have created KATMAP, a framework for predicting gene splicing. While DNA is the same across most cells in an organism, gene splicing allows RNA to be remixed to support cells specialized for different tissues. Described in Nature Biotechnology, KATMAP can be used to investigate how splicing mutations give rise to diseases such as cancer and how nucleic acid therapies influence splicing. 

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Showing 681–684 of 684 stories

National Medal of Science Awarded to Rudolf Jaenisch

MIT News

September 27, 2011

Koch Institute member Rudolf Jaenisch has been recognized for his work that has led to major advances in our understanding of mammalian cloning and embryonic stem cells.

KI Director to be Named to National Cancer Advisory Board

The White House

September 21, 2011

In the White House announcement of his appointment, Koch Institute Director Tyler Jacks was recognized by the President for his depth of experience and tremendous dedication to cancer research.

Koch Institute and OMJP launch TRANSCEND

MIT News

June 28, 2010

KI announced a major strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals, Inc., and its affiliates, called TRANSCEND, whereby the parties will begin to collaborate in multiple areas of oncology research and technology development.

David H. Koch Gives $100 Million to MIT for Cancer Research

MIT News

October 9, 2007

MIT has announced a $100 million gift from Koch Industries executive and MIT alumnus David H. Koch that will usher in new paradigms in highly integrative cancer research. The gift will bring together MIT scientists and engineers under one roof to develop new and powerful ways to detect, diagnose, treat, and manage this often deadly disease.